Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer
NCT00946881
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
WST 11 -mediated -VTP
Sponsor
Steba Biotech S.A.